Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Harmony Biosciences Holdings, Inc. | hrmy-ex321_377.htm |
| EX-31.2 - EX-31.2 - Harmony Biosciences Holdings, Inc. | hrmy-ex312_380.htm |
| EX-31.1 - EX-31.1 - Harmony Biosciences Holdings, Inc. | hrmy-ex311_379.htm |
| 10-Q - 10-Q - Harmony Biosciences Holdings, Inc. | hrmy-10q_20210331.htm |
Exhibit 32.2
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Harmony Biosciences Holdings, Inc. (the “Company”) for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|
Date: May 11, 2021 |
By: |
/s/ Sandip Kapadia |
|
|
|
Sandip Kapadia |
|
|
|
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as a part of the Report or on a separate disclosure document.